1. 18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial. Issue 9 (September 2019) Authors: Calais, Jeremie; Ceci, Francesco; Eiber, Matthias; Hope, Thomas A; Hofman, Michael S; Rischpler, Christoph; Bach-Gansmo, Tore; Nanni, Cristina; Savir-Baruch, Bital; Elashoff, David; Grogan, Tristan; Dahlbom, Magnus; Slavik, Roger; Gartmann, Jeannine; Nguyen, Kathleen; Lok, Vincent; Jadvar, Hossei... Journal: Lancet oncology Issue: Volume 20:Issue 9(2019) Page Start: 1286 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 68Ga-PSMA-PET/CT in Patients With Biochemical Prostate Cancer Recurrence and Negative 18F-Choline-PET/CT. (July 2016) Authors: Bluemel, Christina; Krebs, Markus; Polat, Bülent; Linke, Fränze; Eiber, Matthias; Samnick, Samuel; Lapa, Constantin; Lassmann, Michael; Riedmiller, Hubertus; Czernin, Johannes; Rubello, Domenico; Bley, Thorsten; Kropf, Saskia; Wester, Hans-Juergen; Buck, Andreas K.; Herrmann, Ken Journal: Clinical nuclear medicine Issue: Volume 41:Number 7(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 717 AMG 160, a prostate-specific membrane antigen (PSMA)-targeted BiTE® immuno-oncology therapy, is active in models of advanced prostate cancer that are resistant to radioligand therapy. (10th December 2020) Authors: Lueckerath, Katharina; Bailis, Julie; Current, Kyle; Salvati, Mark; Radu, Caius; Czernin, Johannes Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A429 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 717 AMG 160, a prostate-specific membrane antigen (PSMA)-targeted BiTE® immuno-oncology therapy, is active in models of advanced prostate cancer that are resistant to radioligand therapy. (9th November 2020) Authors: Lueckerath, Katharina; Bailis, Julie; Current, Kyle; Salvati, Mark; Radu, Caius; Czernin, Johannes Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A759 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Activation of the "Splenocardiac Axis" by electronic and tobacco cigarettes in otherwise healthy young adults. Issue 17 (12th September 2017) Authors: Boas, Zachary; Gupta, Pawan; Moheimani, Roya S.; Bhetraratana, May; Yin, Fen; Peters, Kacey M.; Gornbein, Jeffrey; Araujo, Jesus A.; Czernin, Johannes; Middlekauff, Holly R. Journal: Physiological reports Issue: Volume 5:Issue 17(2017) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Comparison of visual and semiquantitative analysis of 18F-FDOPA-PET/CT for recurrence detection in glioblastoma patients. Issue 4 (4th December 2013) Authors: Herrmann, Ken; Czernin, Johannes; Cloughesy, Timothy; Lai, Albert; Pomykala, Kelsey L.; Benz, Matthias R.; Buck, Andreas K.; Phelps, Michael E.; Chen, Wei Journal: Neuro-oncology Issue: Volume 16:Issue 4(2014:Apr.) Page Start: 603 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. From In Situ to In Vivo: An In Situ Click‐Chemistry‐Derived Carbonic Anhydrase II Imaging Agent for Positron Emission Tomography. Issue 1 (3rd December 2012) Authors: Mocharla, Vani P.; Walsh, Joseph C.; Padgett, Henry C.; Su, Helen; Fueger, Barbara; Weber, Wolfgang A.; Czernin, Johannes; Kolb, Hartmuth C. Journal: ChemMedChem Issue: Volume 8:Issue 1(2013:Jan.) Page Start: 43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Incidental Detection of Elastofibroma Dorsi With 68Ga-FAPI-46 and 18F-FDG PET/CT in a Patient With Esophageal Cancer. (February 2021) Authors: Hayrapetian, Artineh; Girgis, Mark D.; Yanagawa, Jane; French, Samuel W.; Schelbert, Heinrich R.; Auerbach, Martin S.; Czernin, Johannes; Calais, Jeremie Journal: Clinical nuclear medicine Issue: Volume 46:Number 2(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Inside Cover: From In Situ to In Vivo: An In Situ Click‐Chemistry‐Derived Carbonic Anhydrase II Imaging Agent for Positron Emission Tomography (ChemMedChem 1/2013). Issue 1 (23rd December 2012) Authors: Mocharla, Vani P.; Walsh, Joseph C.; Padgett, Henry C.; Su, Helen; Fueger, Barbara; Weber, Wolfgang A.; Czernin, Johannes; Kolb, Hartmuth C. Journal: ChemMedChem Issue: Volume 8:Issue 1(2013:Jan.) Page Start: 2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Isoquinoline thiosemicarbazone displays potent anticancer activity with in vivo efficacy against aggressive leukemias. Issue 3 (24th February 2020) Authors: Sun, Daniel L.; Poddar, Soumya; Pan, Roy D.; Rosser, Ethan W.; Abt, Evan R.; Van Valkenburgh, Juno; Le, Thuc M.; Lok, Vincent; Hernandez, Selena P.; Song, Janet; Li, Joanna; Turlik, Aneta; Chen, Xiaohong; Cheng, Chi-An; Chen, Wei; Mona, Christine E.; Stuparu, Andreea D.; Vergnes, Laurent; Reue, K... Journal: RSC medicinal chemistry Issue: Volume 11:Issue 3(2020) Page Start: 392 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗